Nj State Employees Deferred Compensation Plan Elanco Animal Health Inc Transaction History

Nj State Employees Deferred Compensation Plan

  • $800 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
SELL
$19.63 - $26.62 $180,674 - $245,010
-9,204 Closed
0 $0
Q3 2020

Oct 27, 2020
BUY
$21.1 - $29.13 $194,204 - $268,112
9,204 New
9,204 $257,000
Q2 2020

Aug 03, 2020
SELL
$18.94 - $24.93 $174,323 - $229,455
-9,204 Closed
0 $0
Q2 2019

Jul 24, 2019
SELL
$31.11 - $34.79 $31 - $34
-1 Reduced 0.01%
9,204 $311,000
Q1 2019

May 01, 2019
BUY
$29.0 - $32.83 $266,945 - $302,200
9,205 New
9,205 $295,000

Others Institutions Holding ELAN

# of Institutions
438
Shares Held
448M
Call Options Held
1.16M
Put Options Held
1.12M
View Full List

About Elanco Animal Health Inc

ELAN Quotes by TradingView
  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.22B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Nj State Employees Deferred Compensation Plan Portfolio

Follow Nj State Employees Deferred Compensation Plan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email